Evaluation of "Plan A"

计划入组 1,770 人 · 首次发布于 2017 年 8 月 3 日

Plan A Novel Delivery Device Study

计划入组 24 人 · 首次发布于 2025 年 3 月 24 日

Plan A Occlusion and Reversal System Feasibility Study

计划入组 40 人 · 首次发布于 2026 年 1 月 22 日

Autoimmune(Remedy Plan)

Obesity(Remedy Plan)

Coenzyme A

C₂₁H₃₆N₇O₁₆P₃S · Rx

Remedy Plan, Inc.

United States

VISION SERVICE PLAN

United States

Kaiser Foundation Health Plan Of Georgia, Inc.

United States

Aethlon Medical Expands Equity Incentive Plan and Advances Hemopurifier Clinical Trials

Remedy Plan Advances First-in-Class Hyperbolic NAMPT Inhibitor RPT1G Into Cohort 2 in R/R AML and HR-MDS; FDA Accepts Solid Tumor IND

NEXT Life Sciences Secures $200K Grant to Advance Novel Male Contraceptive Hydrogel